title: Prostate cancer: ROR-γ drives androgen receptor expression.
authors.forename: Louise
authors.initials: L
authors.lastname: Stone
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D001549:Benzamides; D002470:Cell Survival / Q000187:drug effects; D016208:Databases, Factual; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D005956:Glucose-6-Phosphate Isomerase; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D009570:Nitriles; D056920:Nuclear Receptor Coactivator 1 / Q000378:metabolism; D056921:Nuclear Receptor Coactivator 3 / Q000378:metabolism; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3 / Q000037:antagonists & inhibitors / Q000235:genetics*; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D020005:Propanols / Q000494:pharmacology; D064129:Prostatic Neoplasms, Castration-Resistant / Q000235:genetics* / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D020218:Response Elements; D014410:Tumor Stem Cell Assay
chemical_list: C575715:1,1,1,3,3,3-hexafluoro-2-(2-fluoro-4'-((4-(pyridin-4-ylmethyl)piperazin-1-yl)methyl)-(1,1'-biphenyl)-4-yl)propan-2-ol; D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3; D010879:Piperazines; D020005:Propanols; D012333:RNA, Messenger; C539900:RORC protein, human; D010669:Phenylthiohydantoin; C540278:enzalutamide; C538859:NCOA1 protein, human; C538866:NCOA3 protein, human; D056920:Nuclear Receptor Coactivator 1; D056921:Nuclear Receptor Coactivator 3; D005956:Glucose-6-Phosphate Isomerase